Coronary IVUS
philips landing enhanced mr large

See clearly.
Treat optimally.


Contact information

* This field is mandatory


By specifying your reason for contact we will be able to provide you with a better service.

We work with partners and distributors who may contact you about this Philips product on our behalf.


Final CEE consent

Angiography alone is  not enough in PCI 

Angiography provides information on luminal characteristics of vessels, but does not provide a clear picture of the vessel and disease.

However, with IVUS guidance you can see more clearly and improve patient outcomes with informed pre-stent planning and post-stent optimization.1

IVUS icon


of the time, IVUS use resulted in a change in PCI strategy2,3,4,5

Arrow icon


Reduction in TVF at 1 year when IVUS was used6,7

Lower risk icon


Lower risk of cardiac death associated with IVUS8

See clearly and treat optimally with IVUS in a variety of clinical scenarios

See clearly and treat optimally with IVUS in a variety of clinical scenarios

Left main


IVUS is an AHA/ACC/SCAI Class IIa recommendation for the assessment of angiographically indeterminant left main CAD.9

IVUS may help to determine:

• Lesion significance

• Vessel sizing

• Optimal stent deployment

left main bubble

Ostial and bifurcation lesions


IVUS guidance reduced long-term all-cause mortality by 76%.10

IVUS may help to determine:

• Location of the true ostium to decrease risk of geographic miss

• Plaque distribution

• Whether two stents are needed

• Lesion length

• Landing zones

• Whether post-dilation is needed (especially at the proximal stent)

ambiguous angio gram bubble

Diffuse disease


Using IVUS for long lesions (stents ≥ 28mm) was associated with a 52% reduction in

MACE at 1 year in the IVUS-XPL randomized control trial.11

IVUS may help to determine:

• Vessel size and length of disease

• Positive remodeling

• Plaque burden

• Stenosis

diffuse disease bubble

Repeat patients

IVUS is an AHA/ACC/SCAI Class IIa recommendation to determine the mechanism of stent restenosis.

IVUS may help to determine:

• Extent and mechanism of restenosis for optimal treatment strategy and for the decrease of risk of geographic miss

• Location and amount of thrombus

ambiguous angio gram bubble

Ambiguous angiogram


IVUS guidance was associated with less contrast: 20 ml vs. 64.5 ml, p<.001, n=83 patients randomized to IVUS or angiographyguided PCI.12

IVUS may help to determine:

• Pathology at the ambiguous site to optimize your treatment strategy

• Device utilization without additional radiation and contrast

ambiguous angio gram bubble
enhance throughput time large

Get advanced insight from your pullback

Experience the advanced imaging insights from Philips ChromaFlo and IVUS Co-registration and improve your treatment strategies.

Coronary IVUS catheters

IVUS expert ipad

Become an IVUS expert

Advance your IVUS imaging skills with interactive workflows and detailed image interpretation practice. The Philips Coronary IVUS Tutor app is free to download in the App Store or Google Play.

Cardio app

Practice using IVUS in cases

Experience the interactive educational app CardioEx which now features new cases on Philips IVUS, physiology and co-registration. Cardio Ex app is free to download in the App Store or Google Play.

Philips elite academy logo

Philips ELIITE Academy is focused on delivering high value and real-time strategic educational programs that meet the evolving needs of our customers. For more information on the available courses, please visit

Keythought leaders icon

Key thought leaders

Clinical expertise icon

Clinical expertise

Product knowledge icon

Product knowledge 

* Co-registration tools available within IntraSight 7 configuration via SyncVision

1 A. Maehara, M. Matsumura, Z.A. Ali, G.S. Mintz, G.W. Stone. IVUS-guided versus OCT-guided coronary stent implantation. J Am Coll Cardiol Img, 10 (2017), pp. 1487- 1503

2 Elgendy IY et al. Outcomes with intravascular ultrasound-guided stent implantation: a meta-analysis of randomized trials in the era of drug eluting stents. Circ-Cardiovasc Interv.2016;9:e003700

3 Ahn JM, Kang SJ, Yoon SH, et al. Meta-analysis of outcomes after intravascular ultrasound-guided versus angiography-guided drug-eluting stent implantation in 26,503 patients enrolled in three randomized trials and 14 observational studies. Am J Cardiol. 2014;113:1338-1347. Hyperlink “”

4 Witzenbichler B, et al. Relationship between intravascular ultrasound guidance and clinical outcomes after drug-eluting stents: The ADAPT-DES study. Circulation. 2014 Jan:129,4;463-470.

5 Singh V, Badheka AO, Arora S, et al. Comparison of in-hospital mortality, length of hospitalization, costs, and vascular complications of percutaneous coronary interventions guided by ultrasound versus guided by angiography. Am J Cardiol. Online 18 Feb 2015.

6 TVF categorized as cardiac death, target vessel MI, and clinical driven TVR

7 Zhang J et al. The ULTIMATE trial. Journal of the American College of Cardiology (2018), , accepted September 13 2018.

8 Choi K, et al. Impact of Intravascular Ultrasound-Guided Percutaneous Coronary Intervention on Long-Term Clinical Outcomes in Patients Undergoing Complex Procedures. JACC: Cardivascular Interventions. Mar 2019, 4281; DOI: 10.1016/j.jcin.2019.01.227

9 Levine et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation 2011;124:e574-651]

10 Kim S, Kim Y, et al. Long-term outcomes of intravascular ultrasound-guided stenting in coronary bifurcation lesions. Am J Cardiol. 2010;106(5):612-8]

11 Hong, S-J et al. Effect of Intravascular Ultrasound–Guided vs Angiography-Guided Everolimus-Eluting Stent Implantation: The IVUS-XPL Randomized Clinical Trial. JAMA, published online November 10, 2015.

12 Mariani et al. MOZART study. JACC Interventions 2014; 7:1287-93.

You are about to visit a Philips global content page


You are about to visit a Philips global content page


Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.